↓ Skip to main content

United States Food and Drug Administration’s authorization of reduced exposure claims for IQOS®: implications for regulation in Latin America

Overview of attention for article published in Revista Panamericana de Salud Pública, October 2022
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
12 Mendeley